Publicaciones en las que colabora con Raúl J. Andrade Bellido (11)

2022

  1. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study

    Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 6, pp. 1604-1612

2016

  1. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: The influence of human leucocyte antigen alleles

    Pharmacogenetics and Genomics, Vol. 26, Núm. 9, pp. 414-422

  2. Killer immunoglobulin-like receptor profiles are not associated with risk of amoxicillin-clavulanate-induced liver injury in Spanish patients

    Frontiers in Pharmacology, Vol. 7, Núm. AUG

2015

  1. Erratum: Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort (PLoS ONE (2015) 9:4 (e94675) (DOI:10.1371/journal.pone.0094675))

    PLoS ONE

2014

  1. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort

    PLoS ONE, Vol. 9, Núm. 4

2013

  1. HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity

    PLoS ONE, Vol. 8, Núm. 7

  2. Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury

    Liver International, Vol. 33, Núm. 9, pp. 1378-1385

2009

  1. Corrigendum to "Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome" [J Hepatol 49 (2008) 107-114] (DOI:10.1016/j.jhep.2008.03.017)

    Journal of Hepatology

2008

  1. Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome

    Journal of Hepatology, Vol. 49, Núm. 1, pp. 107-114

2007

  1. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)

    British Journal of Pharmacology, Vol. 150, Núm. 6, pp. 808-815